U.S. General Merchandise and Department Stores Stock News

NasdaqGM:HIFS
NasdaqGM:HIFSBanks

Hingham Institution for Savings (HIFS) Stock Highlights Net Interest Margin Upside To Bullish Narratives

Hingham Institution for Savings (HIFS) opened Q2 2026 with total revenue of US$42.4 million and basic EPS of US$11.59, supported by net income of US$25.4 million, setting a clear earnings tone for the quarter. The bank has seen quarterly revenue move from US$20.4 million and EPS of US$4.32 in Q2 2025 to US$34.5 million with EPS of US$9.49 in Q4 2025, before reaching the latest Q2 2026 levels, while trailing twelve month EPS stood at US$30.33 on revenue of US$119.5 million. With a reported net...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Gibraltar Industries (ROCK) Sells Renewables Business To Refocus On Core Markets

Gibraltar Industries (NasdaqGS:ROCK) has completed the sale of its Renewables business. The company is repositioning around core markets including residential, agtech, and infrastructure. The transaction reshapes Gibraltar Industries’ business mix and long term focus. The exit from renewables marks a clear refocus for Gibraltar Industries, which now centers its portfolio on residential products, controlled environment agriculture, and infrastructure solutions. For investors, this means the...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

PTC (PTC) On New AI And Partnership Moves With An Undervalued Narrative

Why recent product and partnership moves matter for PTC stock PTC (PTC) has been busy on several fronts, launching the Onshape Labs early access program for AI features, expanding into hospital based 3D printed implants, and teaming up with Whatfix on Product Lifecycle Management adoption. See our latest analysis for PTC. Despite the recent product launches and partnerships, PTC’s share price has fallen about 27% year to date and the 1 year total shareholder return is down about 38%. Recent...
NasdaqGM:SION
NasdaqGM:SIONBiotechs

Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns

Sionna Therapeutics stock has delivered a sharp 195.2% return over the past year, yet its low value score and overvalued reading on the market multiples raise questions about how much upside is already reflected in the price. Over the past 1 year, Sionna Therapeutics has returned 195.2%, which puts the recent share price strength firmly in focus for anyone thinking about valuation. Expectations for the company’s drug pipeline can support a premium, but uncertainty around execution,...
NYSE:TNL
NYSE:TNLHospitality

Travel + Leisure (TNL) Stock Could Be 36% Undervalued Despite Resort Acquisition News

Travel + Leisure stock has delivered a 96.3% return over the past three years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and earnings-based multiples still point to the shares trading at a discount to what the business may be worth. With the stock recently at US$73.27 and fresh acquisition news in play, the central question is whether the current price already reflects that upside. Over the last three years, Travel + Leisure has returned 96.3%, which puts extra focus...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Is June’s 10.6% Sales Jump and Dividend Payout Altering The Investment Case For Costco Wholesale (COST)?

Earlier this month, Costco Wholesale reported that net sales for June reached US$29.24 billion for the five weeks ended July 5, 2026, a 10.6% increase from the same period last year. This performance underlines how Costco’s membership-fee model and recurring cash flows continue to underpin its ability to fund regular dividends, including the recently declared US$1.47 per-share quarterly payout due in August. We’ll now examine how June’s double-digit sales growth and membership-driven cash...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

CareDx (CDNA) Is Up 39.4% After Final Medicare Coverage Clarifies Transplant Test Reimbursement Limits

CareDx, Inc. recently secured a final Medicare Local Coverage Determination that confirms and aligns reimbursement for its AlloSure and AlloMap transplant surveillance tests in kidney, heart, and lung, including defined test frequencies for the critical first three years post-transplant. This decision reduces reimbursement uncertainty and more closely matches actual clinical testing patterns, potentially giving CareDx clearer visibility into demand and test utilization across its transplant...
NYSE:RVLV
NYSE:RVLVSpecialty Retail

What Revolve Group (RVLV)'s Q1 Revenue Beat and Buyer Growth Means For Shareholders

Earlier this year, Revolve Group reported strong Q1 results, with revenue coming in 4.2% above analyst expectations and its buyer base expanding, which management linked to effective execution and market share gains. This combination of outperformance and customer growth suggests the company’s efforts in merchandising, marketing, and technology are translating into tangible operating momentum. Now we’ll explore how this revenue beat and expanding customer base may influence Revolve Group’s...
NYSE:RF
NYSE:RFBanks

Regions Financial (RF) Stock Asset Quality Improvement Reinforces Bullish Credit Narrative

Regions Financial (RF) opened Q2 2026 with total revenue of US$1,839 million and basic EPS of US$0.64, supported by net income excluding extra items of US$549 million. The company has seen quarterly revenue move from US$1,779 million in Q2 2025 to US$1,839 million in Q2 2026, while basic EPS shifted from US$0.59 to US$0.64 over the same period, giving investors a clearer view of how the income line is tracking. With a trailing net profit margin of 29.7% and a net interest margin of 3.66%, the...
NYSE:CSW
NYSE:CSWBuilding

CSW Industrials (CSW) Stock Looks Fully Priced With Rich Cash Flow And Earnings

CSW Industrials stock has delivered a strong 145.0% return over the past 5 years, yet current checks point to shares trading at a premium, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples indicating the valuation may be ahead of the fundamentals. Over 5 years, CSW Industrials has returned 145.0%, which puts more focus on whether the current share price already reflects much of the company’s progress. Expectations for CSW Industrials to keep converting...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast (CMCSA) Split Sparks Talk That Netflix Could Target NBCUniversal

Comcast (NasdaqGS:CMCSA) has announced a plan to separate its cable and media operations. Following this move, market speculation has emerged around a potential future acquisition of NBC Universal by Netflix. An analyst has highlighted NBC Universal as a possible acquisition target, drawing attention to the implications for both companies. Comcast operates a large cable and broadband business alongside its media assets under NBC Universal, covering film, television and streaming. The...
NYSE:PNFP
NYSE:PNFPBanks

Pinnacle Financial Partners (PNFP) Stock Looks Cheap On Fair Value Yet Full On Earnings

Pinnacle Financial Partners stock has delivered a 49.6% total return over the past three years, yet on current checks it screens as only a low-score value pick, while the Excess Returns intrinsic value estimate suggests the shares trade at a steep discount to fair value. That tension between a solid multi year return, an intrinsic value signal implying 42.1% upside and broader checks that lean cautious is what investors now have to weigh. A 49.6% return over three years points to a stock...
NasdaqGS:WEN
NasdaqGS:WENHospitality

Is Wendy's (WEN) Cheap Following Project Fresh Traffic And Margin Pressure?

Recent commentary on Wendy's (WEN) centers on its Project Fresh turnaround, as the company works through declining U.S. traffic, compressed margins, and ongoing earnings and sales pressures amid stronger momentum at competitors like Chipotle. See our latest analysis for Wendy's. Recent share price action has been mixed for Wendy's, with a 14.12% 30 day share price return and an 8.84% 90 day share price return. However, a year to date share price decline of 5.02% and a 1 year total shareholder...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Has Sarepta Therapeutics (SRPT) Fallen Below Fair Value After FDA Progress?

Sarepta Therapeutics stock is coming off a long period of weak share price performance, with a steep decline over the past three years sitting alongside a mixed valuation profile and fresh regulatory progress that could influence how investors think about what the shares are worth today. Over the past three years, Sarepta Therapeutics has fallen 83.7%, which places the current valuation in the context of a prolonged drawdown rather than a recent rally. The FDA’s acceptance of supplemental...
NasdaqGS:FFIN
NasdaqGS:FFINBanks

Is First Financial Bankshares (FFIN) Undervalued On Stronger Quarterly Results?

Why First Financial Bankshares Is Back On Investors’ Radar First Financial Bankshares (FFIN) is back in focus after reporting second quarter and first half 2026 results that showed higher net interest income, net income, and earnings per share versus the prior year. See our latest analysis for First Financial Bankshares. Following the earnings release, First Financial Bankshares’ share price has gained 7.8% over the past month and 17.7% year to date to US$35.32, although the 1 year total...
NYSE:DV
NYSE:DVMedia

DoubleVerify Holdings (DV) Slips With Tech, Is It Still Below Fair Value?

Tech stocks, including DoubleVerify Holdings (DV), came under pressure after an oil shock and a renewed U.S. naval blockade on Iran raised concerns about prolonged higher interest rates and tighter funding conditions. See our latest analysis for DoubleVerify Holdings. The latest pullback in DoubleVerify Holdings reflects the broader risk-off mood in tech, with the stock down 3.22% on a 1 day share price return basis and 2.14% over 7 days. Its 30 day share price return of 10.55% and year to...
NYSE:AXTA
NYSE:AXTAChemicals

Is Axalta Coating Systems (AXTA) Still Below Fair Value Following Its Recent Pullback?

Axalta Coating Systems (AXTA) stock has recently drawn attention after a pullback, with the share price down about 7% over the past month despite a gain over the past 3 months. See our latest analysis for Axalta Coating Systems. Across a longer horizon, Axalta Coating Systems has a 1 year total shareholder return of 8.89%. The share price return over the past 90 days of 8.96% contrasts with the recent 30 day decline of 7.02%, suggesting momentum has cooled after a stronger quarter. If you are...
NYSE:FR
NYSE:FRIndustrial REITs

First Industrial Realty Trust (FR) Draws Valuation Focus, Is Fair Value Already Priced In?

First Industrial Realty Trust (FR) has drawn investor attention after recent share price moves, with the stock last closing at US$68.86. That puts its market value at about US$9.43b. See our latest analysis for First Industrial Realty Trust. Recent trading suggests interest in First Industrial Realty Trust is building, with a 30-day share price return of 11.42% and a year-to-date share price return of 18.93%, while the 1-year total shareholder return stands at 42.38%. If this kind of momentum...
NYSE:BRBR
NYSE:BRBRPersonal Products

The Bull Case For BellRing Brands (BRBR) Could Change Following CEO Transition To Michael Axelrod – Learn Why

In July 2026, BellRing Brands announced that Michael Axelrod will become its Chief Executive Officer, President and a Board member, succeeding retiring CEO Darcy Davenport, who will remain as a senior advisor to support the transition. Axelrod brings more than three decades of consumer packaged goods experience, including prior CEO roles and operational leadership across multiple food and beverage companies, which may influence how BellRing executes on innovation, operations and customer...
NYSE:UVE
NYSE:UVEInsurance

Universal Insurance Holdings (UVE) Stock May Be 32% Undervalued On Earnings Strength

Universal Insurance Holdings has delivered a very strong 265.7% total return over the past 5 years, yet its current valuation checks and intrinsic value estimate both indicate the stock still trades at a discount to what the business may be worth. With the share price at US$38.91, the Excess Returns model and earnings multiples are broadly aligned in suggesting the market could be pricing Universal Insurance Holdings below its intrinsic value. Over 5 years, the stock is up 265.7%, which puts...
NasdaqGS:GRPN
NasdaqGS:GRPNMultiline Retail

Is Groupon (GRPN) Fully Valued On Its 20% Headcount Cut And New COO?

Groupon (GRPN) is back on investors’ radar after a fresh analyst view linked its revised fair value estimate to a board-approved 20% headcount reduction and the appointment of Aditya Rajkumar as Chief Operating Officer. See our latest analysis for Groupon. The fresh analyst view arrives after a sharp 71.9% 1 month share price return and an 86.2% 3 month share price return, although Groupon’s 1 year total shareholder return declined 14.2% while its 3 year total shareholder return is a little...
NYSE:SXC
NYSE:SXCMetals and Mining

Brazil Tariffs Could Lift These US Industrial Stocks

The new US tariffs on Brazilian imports are shaking up expectations for US industrial and manufacturing stocks, from steel and paper to agricultural and electrical machinery. With certain Brazilian goods facing total tariffs of up to 37.5% and others exempt, some US companies could see fresh tailwinds while others face new cost and supply questions. This article focuses on US Domestic Industrial & Manufacturing Stocks that are exposed to these trade shifts and may be influenced by changing...
NYSE:KMT
NYSE:KMTMachinery

Kennametal (KMT) Could Be 9% Below Fair Value On Analyst Downgrades

Analyst Downgrades Put Kennametal Back in Focus Kennametal (KMT) is back on investors’ radar after back to back downgrades from JP Morgan and Morgan Stanley triggered a meaningful one day share price drop and renewed attention on analyst sentiment. See our latest analysis for Kennametal. At around $33.74, Kennametal's recent 1 day share price return fell 5.04% on the downgrades, extending a 30 day share price return decline of 7.10%. However, the year to date share price return is up 16.38%...
NasdaqCM:ATLO
NasdaqCM:ATLOBanks

Ames National (ATLO) Stock Highlights Stronger Net Interest Margin Challenging Long‑Term Earnings Concerns

Ames National (ATLO) has posted Q2 2026 results with total revenue of US$18.9 million and net income of US$5.9 million, translating to basic EPS of US$0.67 and a trailing twelve month EPS of US$2.59. Over recent quarters the company has seen revenue move from US$16.0 million in Q2 2025 to US$18.9 million in Q2 2026, while quarterly EPS shifted from US$0.51 to US$0.67 and trailing net income reached US$23.0 million. This gives investors a clearer picture of earnings momentum backed by a...